Mirati Therapeutics Inc
Change company Symbol lookup
Select an option...
MRTX Mirati Therapeutics Inc
JKS JinkoSolar Holding Co Ltd
AGFY Agrify Corp
YUM Yum! Brands Inc
MMND Mastermind Inc
GRTX Galera Therapeutics Inc
EVA Enviva Inc
SBLK Star Bulk Carriers Corp
TSP TuSimple Holdings Inc
GLG TD Holdings Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Mirati Therapeutics Inc is a United States-based clinical-stage biotechnology company that is focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. The Company is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. The Company is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, MRTX1719, an investigational PRMT5 inhibitor, and other oncology discovery programs.

Price
Delayed
$52.40
Day's Change
-1.86 (-3.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
53.55
Day's Low
52.05
Volume
(Average)

Today's volume of 489,259 shares is on pace to be in-line with MRTX's 10-day average volume of 1,262,122 shares.

489,259
  • Prev Close
    54.26
  • Today's Open
    53.11
  • Day's Range
    52.05-53.55
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    12:03p ET 02/03/23
  • Last (size)
    7
  • 52-Wk Range
    32.96 - 124.81
    LowHigh
  • (02/07/22 - 05/27/22)
    58.98%
  • 94.9%
  • Market Cap
    3.0B
  • Shares Outstanding
    57.6M
  • -13.38
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 109.02
  • (% of float 01/15/23)
    19.65

Latest News

January 19, 2023
5:00 pm ET
PR Newswire
January 06, 2023
4:00 pm ET
PR Newswire
8:31 am ET
Newsfile
December 22, 2022
4:30 pm ET
PR Newswire
8:42 am ET
MarketWatch
December 21, 2022
5:00 pm ET
PR Newswire
December 13, 2022
4:00 pm ET
PR Newswire
9:03 am ET
MarketWatch
5:00 am ET
BusinessWire
December 12, 2022
6:44 pm ET
PR Newswire
6:42 pm ET
PR Newswire
December 05, 2022
6:10 pm ET
Globe Newswire
6:05 pm ET
PR Newswire
December 02, 2022
8:00 am ET
PR Newswire
November 28, 2022
8:00 am ET
PR Newswire
November 15, 2022
9:01 am ET
PR Newswire
November 08, 2022
4:10 pm ET
PR Newswire
4:05 pm ET
PR Newswire
November 07, 2022
8:15 am ET
BusinessWire
October 28, 2022
8:43 am ET
MarketWatch
September 26, 2022
6:16 am ET
MarketWatch
September 16, 2022
3:00 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.